Chung B C, Mallamo J P, Juniewicz P E, Shackleton C H
Children's Hospital Oakland Research Institute, California 94609.
Steroids. 1992 Nov;57(11):530-6. doi: 10.1016/0039-128x(92)90022-2.
Using unlabeled androsterone as starting material, 5 alpha-[16,16-2H2]androstan-3 alpha-ol-17-one was synthesized by exchange using deuterated potassium methoxide. This labeled androsterone product was reduced by sodium borodeuteride, which gave predominantly trideuterated 5 alpha-androstane-3 alpha, 17 beta-diol. The labeled androstanediol was conjugated with glucuronide by using the Koenig-Knorr reaction with methyl-1-bromo-1-deoxy-2,3,4-tri-O-acetyl-alpha-D-glucopyranosuronate . The dominant product was identified by thermospray high-performance liquid chromatography/mass spectrometry (MS) and electrospray MS as 5 alpha-[16,16,17-2H3]androstane-3 alpha, 17 beta-diol, 17 beta-glucuronide.
以未标记的雄甾酮为起始原料,通过使用氘代甲醇钾进行交换反应合成了5α-[16,16-2H₂]雄甾烷-3α-醇-17-酮。该标记的雄甾酮产物用硼氘化钠还原,主要生成三氘代的5α-雄甾烷-3α,17β-二醇。通过与1-溴-1-脱氧-2,3,4-三-O-乙酰基-α-D-吡喃葡萄糖醛酸甲酯进行柯尼希-克诺尔反应,将标记的雄甾二醇与葡萄糖醛酸结合。通过热喷雾高效液相色谱/质谱(MS)和电喷雾MS鉴定出主要产物为5α-[16,16,17-2H₃]雄甾烷-3α,17β-二醇,17β-葡萄糖醛酸苷。